| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/11/1997 | CN1151312A Hepatitis C capsule and its prepn. method |
| 06/11/1997 | CN1151310A Oral liquid for treatment of heart disease and its prepn. method |
| 06/11/1997 | CN1151309A Tablet paste for treatment of stomachache |
| 06/11/1997 | CN1151308A Medicine for curing chilblain |
| 06/11/1997 | CN1151305A Chinese medicinal herbs compsn. and preparation for ttreatment of cancer |
| 06/11/1997 | CN1151302A Chinese medicine for treatment of stomach trouble |
| 06/11/1997 | CN1151301A High effective rheumatism ointment and its prepn. method |
| 06/11/1997 | CN1151300A Twotooth achyranthes root oral liquid and its prepn. method |
| 06/11/1997 | CN1151299A Pure Chinese medicinal liquid film for burn and its prodn. tech. |
| 06/11/1997 | CN1151297A Anti-cancer decoction |
| 06/11/1997 | CN1151296A Inflammation diminishing and asthma stopping cream |
| 06/11/1997 | CN1151295A Oral Chinese medicinal powder for treatment of disease caused by mental factor |
| 06/11/1997 | CN1151294A External-use ointment for treatment of various kinds of skin disease |
| 06/11/1997 | CN1151293A Oral Chinese medicinal powder for treatment of cancer |
| 06/11/1997 | CN1151292A Medicinal preparation for treatment of tumour |
| 06/11/1997 | CN1151291A Jade-supplementing bagged medicinal preparation and its prepn. method |
| 06/11/1997 | CN1151287A Animal medicinal composition |
| 06/11/1997 | CN1151285A Diclofenac ointment and its prepn. method |
| 06/11/1997 | CN1151284A Method for prepn. of slowly-released medicaments preparation |
| 06/11/1997 | CN1035099C Method for prepn. of protracted effective preparation |
| 06/10/1997 | US5637625 Phospholipid coatings; extended shelf life |
| 06/10/1997 | US5637620 Micro formoterol particles |
| 06/10/1997 | US5637612 Mixture with dipeptidase inhibitor |
| 06/10/1997 | US5637591 Antimicrobial and anticollagenase activity of phenazine-5, 10-dioxide and derivatives |
| 06/10/1997 | US5637568 Composition for the sustained and controlled release of medicamentous substances and a process for preparing the same |
| 06/10/1997 | US5637564 Hydrophilic part derived from sugar, polyol, aminopolyol; hydrophobic part derived from hydrocarbon, linked to hydrophilic part by junction bearing amino acid |
| 06/10/1997 | US5637322 Method for producing composition for solid medicine |
| 06/10/1997 | US5637320 Controlled absorption naproxen formulation for once-daily administration |
| 06/10/1997 | US5637319 Controlled-release preparations |
| 06/10/1997 | US5637318 Increased oxygen penetration of skin |
| 06/10/1997 | US5637317 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same |
| 06/10/1997 | US5637316 Deep penetration of skin |
| 06/10/1997 | US5637315 Intravenously administering free radical scavenger or antioxidant selected from alpha-tocopherol, ascorbic acid 6-palmitate, dihydrolipoic acid, butylated hydroxytoluene and a liposome carrier |
| 06/10/1997 | US5637313 Matrix of starch hydrolysate and mixture of a water soluble and water insoluble bulking agent |
| 06/10/1997 | US5637310 Method of treating prostatic adenocarcinoma |
| 06/10/1997 | US5637309 Including carrier composed of combination of cellulose ether or crystalline cellulose with fat, oil, wax, fatty acid, saccharide and/or polyacrylate ester; for intrathecal implantation |
| 06/10/1997 | US5637306 Use in cosmetics or in topical application of an aqueous dispersion based on nonvolatile organopolysiloxanes and on a crosslinked methacryloyloxyethyltrimethylammonium chloride polymer of homopolymer or copolymer with acrylamide type |
| 06/10/1997 | US5637305 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 06/10/1997 | US5637085 Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site |
| 06/10/1997 | US5636632 Ultrasound-enhanced sampling of materials through the skin |
| 06/10/1997 | CA2122835C Polymer-based osmotic drug delivery system |
| 06/10/1997 | CA2106216C Chewable antacid compositions |
| 06/10/1997 | CA2040460C Drug delivery with thermoreversible gels |
| 06/10/1997 | CA2035325C Low density agglomerate utilizing a carbohydrate binder |
| 06/10/1997 | CA2028725C Polymer mixtures useful in skin care |
| 06/10/1997 | CA2006036C Silanamine and (or) silanecarboxamide silicone water dispersion curable into an elastomer by loss of water |
| 06/07/1997 | CA2192228A1 Pharmaceutical compositions based on mequitazine |
| 06/05/1997 | WO1997020041A1 Method for solubilizing proteins in organic solvents |
| 06/05/1997 | WO1997019703A2 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 06/05/1997 | WO1997019699A1 Drug composition |
| 06/05/1997 | WO1997019692A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | WO1997019687A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | WO1997019683A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 06/05/1997 | WO1997019677A1 Sustained-release drug delivery system |
| 06/05/1997 | WO1997019676A1 Method of producing morphologically uniform microcapsules and microcapsules produced by this method |
| 06/05/1997 | WO1997019675A2 Complex cationic lipids |
| 06/05/1997 | WO1997012583A3 Stable compositions containing n-propargyl-1-aminoindan |
| 06/05/1997 | WO1997010851A3 Nucleic acid delivery vehicle |
| 06/05/1997 | WO1997010810A3 Pharmaceutical granules |
| 06/05/1997 | WO1997009050A3 Tacrine patch |
| 06/05/1997 | DE19648566A1 Isotonic lipid emulsion for parenteral application for nourishment, |
| 06/05/1997 | DE19545044A1 Endoparasitizide Mittel Endoparasiticides means |
| 06/05/1997 | DE19545043A1 Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung Pharmaceutical compositions for oral administration and processes for their preparation |
| 06/05/1997 | DE19544507A1 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |
| 06/05/1997 | CA2239206A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | CA2238944A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | CA2238930A1 Sustained-release drug delivery system |
| 06/05/1997 | CA2238568A1 Method for solubilizing proteins in organic solvents |
| 06/04/1997 | EP0776663A1 Remedy for myotonic dystrophy |
| 06/04/1997 | EP0776662A1 Pharmaceutical compositions containing mequitazine |
| 06/04/1997 | EP0776660A2 Long-lasting release nifedipine preparation |
| 06/04/1997 | EP0776659A1 Delivery device for medicaments by the intravaginal route |
| 06/04/1997 | EP0776657A2 Cosmetic and/or pharmaceutical emulsions |
| 06/04/1997 | EP0776656A1 Cosmetic and/or pharmaceutical emulsions |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776228A1 Orally administrable delivery device |
| 06/04/1997 | EP0776215A1 Device for delivery of substances and methods of use thereof |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0776206A1 Pharmaceutical formulation containing amoxycillin and potassium clavulanate |
| 06/04/1997 | EP0776205A1 Pharmaceutical formulation |
| 06/04/1997 | EP0776202A1 Liposome-encapsulated taxol, its preparation and its use |
| 06/04/1997 | EP0776199A1 Oestradiol transdermal therapeutic system comprising hygroscopic additives |
| 06/04/1997 | EP0776198A1 Transdermal therapeutic system with protection against hydrolysis |
| 06/04/1997 | EP0776197A1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 06/04/1997 | EP0776196A1 Hydrophilic controlled release device |
| 06/04/1997 | EP0776195A1 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
| 06/04/1997 | EP0776194A1 Unilamellar liposomal preparations with high active substance content |
| 06/04/1997 | EP0776193A1 Deposition of materials to surfaces using zwitterionic carrier particles |
| 06/04/1997 | EP0721333A4 Soft-shelled gelatin encapsulated particles |
| 06/04/1997 | EP0705101A4 Antiparasitic compositions |
| 06/04/1997 | EP0705085A4 Molecular transdermal transport system |
| 06/04/1997 | EP0697859B1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 06/04/1997 | EP0661924B1 Surface treatment composition |
| 06/04/1997 | EP0633722B1 Water dispersible granules of liquid pesticides |
| 06/04/1997 | EP0621784B1 An iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 06/04/1997 | CN1151168A Method and compositions for the dry powder formulation of interferons |
| 06/04/1997 | CN1151162A Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same |
| 06/04/1997 | CN1151115A Topical compositions comprising N-acetyl-L-cysteine |
| 06/04/1997 | CN1151114A Nanoparticles stab bilized and filterable in sterile conditions |
| 06/04/1997 | CN1150910A Osteophytosis pill and its compounding method |